Recruiting

Psychological Distress Impact on Cancer Treatment and Quality of Life

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Neoplasms

Over 18 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: July 2025
See protocol details

Summary

Principal SponsorGang Chen, MD
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 22, 2025

Actual date on which the first participant was enrolled.

This study seeks to understand how psychological stress affects people with malignant tumors, particularly focusing on how it influences their ability to stick to treatment plans, their overall health outcomes, and their quality of life. The study is important because dealing with cancer can be incredibly stressful, and understanding these impacts can help improve patient care and support systems. By identifying whether psychological distress alters treatment adherence and outcomes, healthcare providers can develop better strategies to support patients both mentally and physically. Participants in this study will include individuals with malignant tumors, some experiencing psychological distress and others not. They will complete questionnaires known as GAD-7 and PHQ-9, which help measure levels of anxiety and depression. Over three years, researchers will track how well these patients follow their prescribed treatments, their health progress, and their overall quality of life. This information will help determine the role of psychological distress in cancer care, potentially leading to improved support and treatment strategies for patients facing these challenges.

Official TitlePsychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life
NCT07193329
Principal SponsorGang Chen, MD
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

2000 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Neoplasms

Criteria

4 inclusion criteria required to participate
1) Confirmed malignant tumors by imaging or pathology (such as hepatobiliary carcinoma, gastric cancer, breast cancer, lung cancer, etc.)
2) Planning to receive or currently undergoing systemic treatment (such as surgery, chemotherapy, TACE, targeted therapy, etc.)
3) Age ≥18 years old
4) Sign the informed consent form and voluntarily participate in this study
3 exclusion criteria prevent from participating
1) Combined with severe systemic diseases (such as severe cardiovascular and cerebrovascular diseases)
2) There is severe cognitive impairment and it is impossible to complete the questionnaire assessment
3) Incomplete clinical data or loss to follow-up

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

First Affiliated Hospital of Wenzhou Medical University

Wenzhou, ChinaOpen First Affiliated Hospital of Wenzhou Medical University in Google Maps
Recruiting
One Study Center